Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03257917 · ClinicalTrials.gov registry record
Understanding Value in Metastatic Breast Cancer
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 100
- Enrollment target
NCT03257917 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants.
The verdict
NCT03257917 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The overall objective of this project is to gain knowledge about out-of-pocket (OOP) expenses and lost opportunity costs among metastatic breast cancer (MBC) patients. To achieve this objective, MBC patients will be asked to participate in a short, 37-question survey asking questions about the financial burden, OOP expenses, and opportunity costs related to their cancer care
Interventions
- OTHER Understanding value in Metastatic Breast Cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2017-06-13 |
| Est. Completion | 2019-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03257917
The ClinicalTrials.gov registry entry for NCT03257917 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Understanding value in Metastatic Breast Cancer is the first listed.
NCT03257917 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03257917 about?
NCT03257917 is a clinical study titled "Understanding Value in Metastatic Breast Cancer". The overall objective of this project is to gain knowledge about out-of-pocket (OOP) expenses and lost opportunity costs among metastatic breast cancer (MBC) patients. To achieve this objective, MBC patients will be asked to participate in a short, 37-question survey asking questions about the finan...
What is the current status of trial NCT03257917?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2017-06-13. Estimated completion is 2019-07-12.
What interventions are being tested in trial NCT03257917?
The interventions under investigation include: Understanding value in Metastatic Breast Cancer (OTHER).
Who is sponsoring clinical trial NCT03257917?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.